The X-factor in ART: does the use of Assisted Reproductive Technologies influence DNA methylation on the X chromosome?

• Published in: bioRxiv
• Main Authors: Romanowska, Julia, Nustad, Haakon E, Page, Christian M, Denault, William R P, Bohlin, Jon, Lee, Yunsung, Magnus, Maria C, Haftorn, Kristine L, Gjerdevik, Miriam, Novakovic, Boris, Saffery, Richard, Gjessing, Hakon K, Lyle, Robert, Magnus, Per M, Haberg, Siri E, Jugessur, Astanand
• Format: Paper
• Language: English
• Published: Cold Spring Harbor Cold Spring Harbor Laboratory Press 07.10.2022
• Subjects: Autism; CpG islands; DNA methylation; Embryogenesis; Fallopian tube; Infertility; Intellectual disabilities; Neonates; Neurodevelopment; Neurodevelopmental disorders; Replication; Reproductive technologies; Reproductive technology; Testes; X chromosomes
• DOI: 10.1101/2022.10.06.510603

Background: Assisted reproductive technologies (ART) may perturb DNA methylation (DNAm) in early embryonic development. Although a handful of epigenome-wide association studies of ART have been published, none have investigated CpGs on the X chromosome. To bridge this knowledge gap, we leveraged one of the largest collections of mother-father-newborn trios of ART and non-ART (natural) conceptions to date to investigate DNAm differences on the X chromosome. Materials and Methods: The discovery cohort consisted of 982 ART and 963 non-ART trios from the Norwegian Mother, Father, and Child Cohort Study (MoBa). The replication cohort consisted of 149 ART and 58 non-ART neonates from the Australian "Clinical review of the Health of adults conceived following Assisted Reproductive Technologies" (CHART) study. The Illumina EPIC array was used to measure DNA methylation (DNAm) in both datasets. In the MoBa cohort, we performed a set of X-chromosome-wide association studies ("XWASs" hereafter) to search for sex-specific DNAm differences between ART and non-ART newborns. We tested several models to investigate the influence of various confounders, including parental DNAm. We also searched for differentially methylated regions (DMRs) and regions of co-methylation flanking the most significant CpGs. For replication purposes, we ran an analogous model to our main model on the CHART dataset. Results and conclusions: In the MoBa cohort, we found more differentially methylated CpGs and DMRs in girls than boys. Most of the associations persisted even after controlling for parental DNAm and other confounders. Many of the significant CpGs and DMRs were in gene-promoter regions, and several of the genes linked to these CpGs are expressed in tissues relevant for both ART and sex (testis, placenta, and fallopian tube). We found no support for parental infertility as an explanation for the observed associations in the newborns. The most significant CpG in the boys-only analysis was in UBE2DNL, which is expressed in testes but with unknown function. The most significant CpGs in the girls-only analysis were in EIF2S3 and AMOT. These three loci also displayed differential DNAm in the CHART cohort. Overall, genes that co-localized with the significant CpGs and DMRs are implicated in several key biological processes (e.g., neurodevelopment) and disorders (e.g., intellectual disability and autism. These connections are particularly compelling in light of previous findings indicating that neurodevelopmental outcomes differ in ART-conceived children compared to naturally-conceived. Competing Interest Statement The authors have declared no competing interest. Footnotes * https://github.com/folkehelseinstituttet/X-factor-ART